Evidence map›Paper›PMID 24356953›Full record

ArticleThe Journal of biological chemistry2014

A missense mutation in Rev7 disrupts formation of Polζ, impairing mouse development and repair of genotoxic agent-induced DNA lesions.

Maryam Khalaj, Abdolrahim Abbasi, Hiroshi Yamanishi, Kouyou Akiyama, Shuso Wakitani, Sotaro Kikuchi, Michiko Hirose, Misako Yuzuriha, Masaki Magari, Heba A Degheidy and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. REV7: Jack of many trades.Trends in cell biology · 2021
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Biallelic inactivation of REV7 is associated with Fanconi anemia.The Journal of clinical investigation · 2016
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Maryam KhalajFrom the Graduate School of Natural Science and Technology and.
Abdolrahim Abbasi
Hiroshi Yamanishi
Kouyou Akiyama
Shuso Wakitani
Sotaro Kikuchi
Michiko Hirose
Misako Yuzuriha
Masaki Magari
Heba A Degheidy
Kuniya Abe
Atsuo Ogura
Hiroshi Hashimoto
Tetsuo Kunieda
Okayama University · JPRIKEN BioResource Research Center · JPYokohama City University · JPNational Institutes of Health · USUnited States Food and Drug Administration · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Repro22 is a mutant mouse produced via N-ethyl-N-nitrosourea-induced mutagenesis that shows sterility with germ cell depletion caused by defective proliferation of primordial germ cells, decreased body weight, and partial lethality during embryonic development. Using a positional cloning strategy, we identified a missense mutation in Rev7/Mad2l2 (Rev7(C70R)) and confirmed that the mutation is the cause of the defects in repro22 mice through transgenic rescue with normal Rev7. Rev7/Mad2l2 encodes a subunit of DNA polymerase ζ (Polζ), 1 of 10 translesion DNA synthesis polymerases known in mammals. The mutant REV7 did not interact with REV3, the catalytic subunit of Polζ. Rev7(C70R/C70R) cells showed decreased proliferation, increased apoptosis, and arrest in S phase with extensive γH2AX foci in nuclei that indicated accumulation of DNA damage after treatment with the genotoxic agent mitomycin C. The Rev7(C70R) mutation does not affect the mitotic spindle assembly checkpoint. These results demonstrated that Rev7 is essential in resolving the replication stalls caused by DNA damage during S phase. We concluded that Rev7 is required for primordial germ cell proliferation and embryonic viability and development through the translesion DNA synthesis activity of Polζ preserving DNA integrity during cell proliferation, which is required in highly proliferating embryonic cells.

Indexed as

DNA DamageMutation, MissenseAnimalsApoptosisCell Cycle CheckpointsCell ProliferationDNA-Directed DNA PolymeraseDNA Polymerase IIFemaleGerm CellsMad2 ProteinsMaleMiceMice, Mutant StrainsMitomycinNucleic Acid Synthesis InhibitorsDNA-Directed DNA PolymeraseDNA Polymerase IIMad2l2 protein, mouseMad2 ProteinsMitomycinNucleic Acid Synthesis InhibitorsPole protein, mousePoly-ADP-Ribose Binding ProteinsREV3L protein, mouseCell ProliferationDNA PolymeraseEmbryoMouse GeneticsMutant

Identifiers

PMID24356953
PMCPMC3916577
OpenAlexW2076384738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.